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A B S T R A C T
Styrene is a building-block of several compounds used in a wide array of materials and products. The
most important human exposure to this substance occurs in industrial settings, especially among
reinforced-plastics industry workers. The effect of occupational exposure to styrene on cytogenetics
biomarkers has been previously reviewed with positive association observed for chromosomal
aberrations, and inconclusive data for the micronucleus assay. Some limitations were noted in those
studies, including inadequate exposure assessment and poor epidemiological design. Furthermore, in
earlier studies micronuclei frequency was measured with protocols not as reliable as cytokinesis-block
micronucleus (CBMN) assay. Aim of the present systematic review and meta-analysis is to investigate
genomic instability and DNA damage as measured by the CBMN assay in lymphocytes of subjects exposed
to styrene. A total of 11 studies published between 2004 and 2012 were included in the meta-analysis
encompassing 479 styrene-exposed workers and 510 controls. The quality of each study was estimated by
a quality scoring system which ranked studies according to the consideration of major confounders,
exposure characterization, and technical parameters. An overall increase of micronuclei frequencies was
found in styrene-exposure workers when compared to referents (meta-MR 1.34; 95% CI 1.18–1.52), with
signiﬁcant increases achieved in six individual studies. The consistency of results in individual studies,
the independence of this result from major confounding factors and from the quality of the study
strengthens the reliability of risk estimates and supports the use of the CBMN assay in monitoring genetic
risk in styrene workers.
ã 2016 Elsevier B.V. All rights reserved.
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Styrene is a high-volume production chemical precursor to
polystyrene and several other copolymers used extensively in the
production of synthetic rubber, plastic, insulation, ﬁberglass,
automobile components, food containers and latex paints [1].
The highest level of human exposure occurs in occupational
settings during industrial synthesis and manufacturing of styrene-
containing products. According to literature, subjects more heavily
exposed are reinforced-plastics industry workers, and to a lesser
extent styrene-butadiene rubber industry workers [2]. In these
settings, absorption of styrene occurs mainly through inhalation
and, to a minor extent, via skin contact [3]. Although environmen-
tal exposure typically occurs at much lower levels than occupa-
tional exposure, general population is exposed through
mainstream cigarette smoke, motor vehicle exhaust, and newly
installed carpets containing styrene–rubber latex adhesive [1]. The
ﬁrst step of styrene metabolism is usually the cytochrome P450
(CYP)-mediated oxidation to styrene-7,8-oxide (SO) an electro-
philic intermediate capable of binding covalently to macro-
molecules and considered to be directly responsible for the
genotoxic effects of styrene [3]. SO can be detoxiﬁed by glutathione
conjugation or converted to styrene glycol by microsomal epoxide
hydrolase and excreted in urine in the form of mandelic acid (MA)
and phenylglyoxylic acid (PGA) (main route) [1].
Recently the U.S. National Institute of Environmental Health
Sciences listed styrene as reasonably anticipated to be a human
carcinogen based on credible but limited evidence of carcinoge-
nicity in epidemiologic studies, on sufﬁcient evidence of
carcinogenicity in animals, and on convincing evidence that
styrene is genotoxic in exposed humans [2]. The evidence comes
mainly from occupational-cohort studies of reinforced-plastics
workers in Europe and U.S., linking styrene exposure to an
increase frequency of lymphohematopoietic, esophageal, and
pancreatic cancers [4–6]. The proposed mechanisms for the
carcinogenicity of styrene include both genotoxic and epigenetic
pathways [2]. The cytokinesis-block micronucleus (CBMN) assay
in human lymphocytes has become one of the most widely used
methods for measuring chromosomal damage in human cells in
vitro and in vivo [7,8]. In human biomonitoring studies CBMN has
been used for decades as a standard biodosimetry assay to assess
the genotoxic effects of exposure to chemical compounds in
occupational and environmental settings. The assay is also applied
in in vitro genetic toxicology to test new compounds for regulatory
purposes [9]. Since it represents a measure of both chromosome
breakage and chromosome loss, an increased frequency of
micronucleated cells can reﬂect exposure to genotoxic agents
with clastogenic or aneugenic modes of action [10]. Furthermore,
prospective studies evaluating large cohorts of disease-free
subjects revealed that an increase in micronuclei frequency in
peripheral blood lymphocytes was associated with an increasedrisk of cancer, at the population level [11,12], providing suggestive
evidence that micronuclei formation is associated with early
events in carcinogenesis.
Styrene has been shown to induce single strand breaks as well
as cytogenetic damage and aneuploidy in several cell systems in
vitro [13] and in lymphocytes of exposed workers [3,14,15]. Since
the ﬁrst report in 1977, a total of twenty-ﬁve studies were
published measuring the frequency of micronuclei in lymphocytes
of workers exposed to styrene, with both positive and negative
outcomes. Few groups have critically reviewed the data available
on human studies, particularly in relation to cytogenetic endpoints
[3,13,15,16]. Compelling evidence of a positive association between
styrene exposure levels and the frequency of chromosomal
aberrations was found, as for micronuclei frequency the associa-
tion remains inconclusive [3,13,15]. The major weaknesses found
were the limited sample size, the inadequate exposure assessment,
the poor epidemiological design or inappropriate statistical
analysis [15,16] mostly observed in earlier studies. Some of the
studies included in the abovementioned reviews did not used
CBMN assay using other protocols which did not allow a reliable
identiﬁcation of once-divided cells and thus expression of DNA
damage as micronuclei. Others were performed in the early stages
of CBMN assay when methods and scoring criteria were not well
established. Since last meta-analysis study [15] around twelve
cross-sectional studies on occupational exposure to styrene were
published using similar CBMN protocols. Hence, a critical review of
the new available data is needed for a better understanding of
styrene genotoxicity and potential mechanism of carcinogenicity,
as well as the role of micronuclei formation as an early cancer risk
biomarker of human in vivo chemical exposure, particularly to
styrene. The aim of the present study was to retrieve, review and
synthesise published evidence in order to assess the sensitivity of
the CBMN assay to measure DNA damage in lymphocytes of
subjects exposed to styrene.
2. Materials and methods
This systematic review follows the methodology described in
the PRISMA statement [17].
2.1. Eligibility criteria
Eligible for the inclusion in the present review were all studies
on human in vivo exposure to styrene in which DNA damage was
evaluated in lymphocytes by the CBMN assay.
2.2. Search strategy
Studies were identiﬁed by using the MedLine/PubMed database
(National Library of Medicine, National Institutes of Health,
Bethesda, MD, USA; http://www.ncbi.nlm.nih.gov/pubmed/).
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heading associated to ‘styrene exposure’ using AND operator. The
search ﬁlter ‘Humans’ was used to retrieved studies conducted
only in human subjects. Further search using the key heading
‘micronuclei and styrene exposure’ was performed through
Research Gate and two additional publications on human exposure
were identiﬁed from this source.
2.3. Study selection
All retrieved studies were reviewed and assessed by two co-
authors (SC and JPT) for inclusion in the present analysis. Only in
vivo human exposure studies reporting a fully detailed description
of the experimental protocol used for the CBMN test were included
in the meta-analysis. After ﬁrst selection, a number of publications
were discarded because of inadequate study design, relevant co-
exposure to other(s) genotoxic chemical(s) or insufﬁcient data
reporting.
2.4. Data collection process
All studies complying with inclusion criteria were cross-
sectional studies of populations occupationally exposed to styrene
in the workplace. For each study, the following information was
collected: number of styrene-exposed workers and controls; type
of industry/factory; controls origin; styrene exposure indicators
and measurements, namely air-exposure and/or body ﬂuids levels
(biomarkers of exposure); period of body ﬂuids collection (begin or
end of shift); data/use of personal protective equipment (PPE);
information on co-exposure; years of employment (duration of
exposure); lymphocyte micronuclei frequencies expressed as
number of micronucleated binucleated cells (MNed) and/or
frequency of binucleated cells with micronuclei (MNi). Data on
micronuclei frequencies in other tissues, MN-FISH (ﬂuorescence in
situ hybridization) assay and other effect biomarkers were also
listed when available.
2.5. Classiﬁcation of individual studies
A quality score (QS) was calculated for each of the selected
studies to evaluate the standard of study designs. Studies were
classiﬁed according to the following predeﬁned parameters: (i)
number of subjects in control group, (ii) number of subjects in
exposed group (iii) age-matching, (iv) gender-matching, (v)
nutritional status-matching, (vi) smoking status-matching, (vii)
alcohol intake-matching (viii) styrene exposure assessment and,
(ix) number of cells scored per subject. Each parameter scored 1 to
a maximum of 3 points based on reported data and matching
status (not-matched, partly and perfectly matched). Not-matched
(1 point) was considered when factors were signiﬁcantly different
between groups or data was not collected and, partly-matched (2
points) when factors were not statistically different between
groups even though they were not perfectly matched (3 points).
Styrene exposure assessment was scored regarding the method
used: by questionnaire (1 point), air-exposure levels (2 points) or
measurement in body ﬂuids (3 points). The maximum and
minimum of total QS possible is 27 and 9 respectively.
2.6. Statistical methods
We computed the Mean Ratio (MRi) for each study as follows:
MRi = [MN mean (exposed)]/[MN mean (controls)]
This measure of effect is relatively independent from the
absolute values of the means, reduces the extent of interlaboratoryvariability, and increases the comparability across the studies
considered.
To estimate an overall measure of the effect we computed a
weighted mean of the MRis (meta-MR) with weights related to the
variance of MRi in each study. To stabilize the within-study
variances, we performed the calculation transforming the MRi in
its natural logarithm (ln). The variance of ln(MRi) is, approximately,
Var[ln(MRi)] = [Var(mpi)/mpi2] + [Var(mci)/mci2]
where mpi and mci are the mean of micronucleus (MN) frequency
of exposed and control groups, respectively, and Var(mpi) and Var
(mci) are the corresponding variances.
The analysis was carried out using the random effects model [18],
a special form of linear regression model,
ln(MRi) = m + aXi + bi + ti
where the parameter m is ln(meta-MR); a is a vector of
unknown parameters representing the effects of the Xi covariates;
the parameter bi is the residual of the ith-study from the overall
value m and its variance (D2) is estimated from the data; ti is the
error in estimating ln(MRi) in repeated samples from the same
population to which the ith-study belongs; the variance of ti is
assumed to be known and estimated by Var[ln(MRi)].
This model allowed to estimate the amount of the variability
between studies (D2) and accordingly provided suitable estimates
of the standard errors of the parameters.
The differences between exposed and controls in mean age and
in the percentages of males and smokers of each study were
analysed as possible confounders of the meta-MR estimate
through a meta-regression. In addition, the association with
work-related variables was also tested.
To verify if some study strongly inﬂuenced the estimate of the
meta-MR a sensitivity analysis, excluding the studies one at the
time and recomputing the meta-MR, was performed.
As far as publication bias is concerned, we explored the
possibility that only selected studies were published by applying
the Egger’ test [19] and through the visual inspection of the funnel
plot. The analysis was carried out with STATA statistical software
[20].
3. Results
3.1. Results of the literature search
The literature search was carried out in April 2015. Its results
and the stepwise exclusion process for meta-analysis is described
in Fig. 1. A total of 53 publications were retrieved and screened; 37
were not relevant to our analysis and were discarded, as described
in the ﬂow chart. Sixteen full-text articles were assessed for
eligibility and ﬁve of them were excluded because of insufﬁcient
data reporting [21,22], lack of a control group [23] or due to
concurrent exposure to other known genotoxic compounds
[24,25]. As a consequence eleven articles [26–36] were left for
the inclusion in the review.
3.2. Description of the studies
The characteristics of the selected studies are reported in
Table 1. A total of 971 subjects, 479 styrene-exposed workers and
492 controls were included in the analysis. Of the eleven studies
selected, four included less than 20 subjects per study group
[26,27] or in one of the groups [28,29].
Two studies [26,34] were stratiﬁed according to authors’
criteria of “low” or “high” level of exposure to styrene measured
in workplace-air [26,34] and body ﬂuids [26]. Tomanin et al. [26]
comprised workers from two separate factories with higher and
Fig. 1. Flow chart: selection of the literature.
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with separate control groups. Hanova et al. [34] stratiﬁed the
exposed group into two subgroups of “low exposed” and “high
exposed”. Thus in total the eleven studies encompassed thirteen
groups of workers exposed to styrene. For the current review and
meta-analysis sufﬁxes I and II were assigned to references [26] and
[34] whenever necessary to distinguish between “low” (I) and
“high” (II) exposed groups.
All studies but one matched control groups on two or more of
the following variables: age, gender, or smoking habits. Vodicka
et al. [29] was the exception, but according to authors unbalances
between exposed and unexposed were controlled for in the
statistical analysis. Nevertheless, considering this intrinsic limita-
tion, only the data of one subgroup of workers (Plant A) with
similar socio-demographic characteristics of control group (Plant
controls) was included in the meta-analysis. A discrepancy in the
contribution of males and females was found in Tomanin et al. [26I]
and Hannova et al. [34I], with exposed group composed only by
males while controls had both genders. This difference was onlysigniﬁcant for Hannova et al., probably due to the limited sample
size of Tomanin et al. study.
Subjects were interviewed for personal, occupational (previous
exposure to styrene or/and any other known genotoxic com-
pounds) and medical history in eight studies [26–28,31–33,35,36].
Co-exposures to other compounds were assessed in three studies
for acetone, toluene, lead and chromium [30,31,35]. The usage of
personal protective equipment (PPE) during working hours was
enquired in three studies [32,35,36]; just one reported the use of
PPE (gloves and masks) by styrene-exposed workers [32]. The level
of exposure to styrene was determined by air monitoring
[29,31,32,34–36] and/or measurement of styrene or its metabolites
in urine [26–33,35,36] and/or blood [29,34], all studies included a
biomarker of internal dose. Mean levels of airborne-styrene
exposure ranged between studies from 1.2 to 33 ppm. The urinary
excretion of MA and PGA (sum of the main styrene metabolites)
was analysed in six studies [29,31–33,35,36], in ﬁve the reference
value of 400 mg/g creatinine [37] was exceeded [29,31,33,35,36].
Earlier studies only measured the concentration of MA in urine
Table 1
Characteristics of the 11 studies included in the meta-analysis on CBMN and human exposure to styrene (alphabetical order).
Study
(author, occupational
setting, country)
Study population Styrene Exposure
Mean SD
Duration
of exposure
Mean SD
(range)
CBMN assay1 QS Results and comments
(exposed vs controls)
Ref
Anwar and Shamy (1995)
Reinforced plastics
plant, Egypt
Exposed (n =70)
gender: only males
smoking: 35sk + 35nsk
age: 407
Controls (n =68)
gender: only males
smoking: 35sk + 33nsk
age: 417
Dose biomarkers:
Urinary MA (end shift)
10396mg/g creat.
15.16.2 years Lymphocyte culture
CytB–3mg/mL
Slides stained with Giemsa
Visual scoring:
500–1000 BNCs/slide
17 L-MNed (m) $ (1.09) 6.55 vs
6.00
[27]
L-CA (%total) " (2.78) 4.00 vs 1.44
L-CA (%total with
gaps)
" (1.76) 6.06 vs 3.44
L-MNed were correlated with CAs but did
not correlate with age or biomarkers of
dose
Costa et al. (2012)
Fiberglass reinforced
plastics, Portugal
Exposed (n =75)
gender: 54m+21f
smoking: 23sk + 52nsk
age: 3412
Controls (n =77)
gender: 53m+24f
smoking: 23sk + 54nsk
age: 3711
Air (TWA):
30.43.7ppm
Dose biomarkers:
Urinary MA+PGA (next morning)
44344mg/g creat.
9.010.0 years Whole blood culture
CytB–6mg/mL
Slides stained with Giemsa
Visual scoring:
1000 BNCs/slide
22 L-MNed (m) $ (1.15) 2.56 vs
2.22
[36]
L-MNi (m) $ (1.16) 2.63 vs
2.26
L-SCE " (1.28) 5.50 vs 4.31
L-TL $ (1.04) 49.39 vs
47.43
Workers with EPHX1# “high mEH activity”
genotype had signiﬁcantly higher
frequency of SCE compared to workers
with EPHX1 “low mEH activity” genotype
No inﬂuence was found regarding GSTM1,
GSTT1, GSTP1 and CYP2E1 on the endpoints
studied
Godderis et al. (2004)
Fiberglass- reinforced
plastic factory, Belgium
Exposed (n =44)
gender: only males
smoking: 23sk + 21nsk
age: 4210
Controls (n =44)
gender: only males
smoking: 23sk + 21nsk
age: 419
Dose biomarkers:
Urinary MA (end shift)
202148mg/g creat.
14.210.3 years Whole blood culture
CytB–6mg/mL
Slides stained with
Giemsa Visual scoring:
1000 BNCs/slide
21 L-MNed (m) " (1.48) 3.93 vs 2.65 [30]
N-MN (m) " (2.26) 0.52 vs 0.23
L-TD (%) $ (1) 0.80 vs 0.80
Signiﬁcant positive correlation between L-
MNed (m) and duration of exposure; N-MN
(m) and styrene exposure. Signiﬁcant
positive inﬂuence of XRCC1 (399) on L-
MNed frequency (all population)
Potential co-exposures analysed, both
levels of lead in blood and chromiun in
urine were below reference values.
Hanova et al. (2010)
Hand lamination,
Czech Republic
“High” styrene exposure, > 12 ppm
[34II]
Exposed (n =43)
gender: 26m+17f
smoking: 23sk + 20nsk
age: 3711
Air:
32.79.4 ppm*
Dose biomarkers:
Styrene level in blood (mg/L):
1.710.94
4.03.6 years Lymphocyte culture
CytB–6mg/mL
Slides stained with
Giemsa Visual scoring:
2000 BNCs/slide
17 “High” styrene exposure, >12 ppm [34II]: [34]
L-MNed (m) $ (1.06) 7.3 vs 6.8
SSB in DNA (SSB/
109Da)
#(0.43) 0.51 vs 1.20
“Low” styrene exposure,<12 ppm
[34I]
Exposed (n = 28)
gender: only male
smoking: 14sk + 14nsk
age: 4112
Controls (n = 51)
gender: 41m+10f
smoking: 35sk+ 16nsk
age: 4012
Air:
1.21.4 ppm*
Dose biomarkers:
Styrene level in blood (mg/L):
0.410.45
Dose biomarkers:
Styrene level in blood (mg/L):
0.270.25
6.94.0 years 17 “Low” styrene exposure, <12 ppm [34I]:
L-MNed (m) $ (1.06) 7.2 vs 6.8
SSB in DNA (SSB/
109Da)
#(0.64) 0.77 vs 1.20
All population:
mRNA expression levels of XRCC1, hOGG1
and XPC were negatively correlated with
styrene concentration in air and blood and
positively with SSBs
Laffon et al. (2002)
Fiberglass-reinforced-plastics
factory, Spain
Exposed (n =14)
gender: only males
smoking: 5sk + 9nsk
age: 449
Dose biomarkers:
Urinary MA (end shift)
3 samplings
31391mg/g creat.
17.06.0 years Whole blood culture
CytB–6mg/mL
Slides stained with DAPI
16 L-MNed (m) " (1.81) 21.57 vs
11.90
[28]
L-MNi (m) " (1.77) 24.63 vs
13.91
96
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Controls (n =30)
gender: only males
smoking: 16sk + 14nsk
age: 388years
32571mg/g creat.
353153mg/g creat.
Visual scoring:
1000 BNCs/slide
L-SCE/cell " (1.38) 3.51vs 2.55
L-TL (mm) " (1.12) 48.68 vs
43.34
Signiﬁcant association between L-MNed
(m) with duration of exposure (also found
for L-SCE and L-TL)
Among exposed workers no inﬂuence on
the effect biomarkers was observed of
GSTM1 and GSTT1 genotypes
Migliore et al. (2006)
Fiberglass reinforced-plastics
factories, Italy
Exposed (n =42)
gender: only males
smoking: no information
age: 325
Controls (n =25)
gender: only males
smoking: no information
age: 327
Dose biomarkers:
Urinary MA+PGA (end shift)
6304mg/g creat
9.65.8 years Whole blood culture
CytB–6mg/mL
Slides stained with Giemsa
Visual scoring:
2000 BNCs/slide
For FISH analysis slides were stained
with DAPI
18 L-MNed (m) " (2.22) 13.8vs 6.2 [33]
C +MNBN " (2.20) 7.34vs 3.34
C-MNBN " (2.22) 6.09 vs 2.21
% TDNA (sperm
cells)
" (1.49) 11.02 vs 7.42
Migliore et al. (2006)
Fiberglass reinforced plastics
and polyester resin industries,
Italy
Exposed (n =95)
gender: 76m+19f
smoking: 51sk + 44nsk
age: 358
Controls (n =98)
gender: 67m+31f
smoking: 41sk + 57nsk
age: 379
Air:
8.70.9 ppm*
Dose biomarkers:
Urinary MA+PGA (end shift)
300338mg/g creat
11.58.1 years Whole blood culture
CytB–6mg/mL
Slides stained with Giemsa
Visual scoring:
2000 BNCs/slide
For FISH analysis slides were stained
with DAPI
20 L-MNed (m) " (1.50) 13.8 vs 9.2 [32]
C +MNBN " (1.56) 7.43vs 4.75
C-MNBN " (1.80) 5.76 vs 3.20
L-CA (%total) $ (0.96) 2.4 vs 2.5
L-CA (%total with
gaps)
$ (1.06) 3.8 vs 3.6
C +MNBN were signiﬁcantly correlated
with MA+PGA
L-MNed (m) and C+MNBN were
signiﬁcantly
correlated with minor styrene metabolites
in urine (4-VPT)
Among exposed workers GSTT1 null
individuals showed a signiﬁcant higher
frequency of MNed compared to GSTT1
positive subjects.
No signiﬁcant inﬂuence was found
regarding EPHX1, GSTM1, GSTP1 and NAT2
on cytogenetic biomarkers studied.
Teixeira et al (2004)
Reinforced- plastics plants,
Portugal
Exposed (n =28)
gender: 18m+10f
smoking: 8sk + 20nsk
age: 358
Controls (n =28)
gender: 18m+10f
smoking: 9sk + 19nsk
age: 3610
Air (TWA):
27.05.0 ppm (TWA)
Dose biomarkers:
Urinary MA+PGA (next morning)
40173mg/g creat.
12.010.0 years Whole blood culture
CytB–6mg/mL
Slides stained with Giemsa
Visual scoring:
1000 BNCs/slide
20 L-MNed (m) $ (1.30) 3.63 vs
2.78
[31]
L-MNi (m) $ (1.30) 3.68vs
2.82
L-SCE/cell " (1.40) 7.18vs 6.30
GSTM1 null individualswith lower levels of
styrene exposure have signiﬁcantly higher
levels of urinary MA+PGA
Potential co-exposures analysed: toluene
and acetone were present, air levels were
less than 1% of the styrene concentration
Teixeira et al. (2010)
Fiberglass reinforced
plastics, Portugal
Exposed (n =52)
gender: 34m+18f
smoking: only nsk
age: 3412
Controls (n =54)
gender: 36m+18f
smoking: only nsk
age: 3711
Air (TWA):
29.94.4ppm (TWA)
Dose biomarkers:
Urinary MA+PGA (next morning)
41952mg/g creat.
10.010.0 years Whole blood culture
CytB–6mg/mL
Slides stained with Giemsa
Visual scoring:
1000 BNCs/slide
22 L-MNed (m) $ (1.08) 2.44 vs
2.26
[35]
L-MNi (m) $ (1.08) 2.50 vs
2.31
L-SCE " (1.23) 5.34 vs 4.15
L-TL $ (1.03) 49.20vs
47.64
L-MNi were signiﬁcantly correlated with
L-SCE
Potential co-exposures analysed: toluene
and acetone were present, air levels
were<1% of the styrene concentration
6.24.7 years 17 “Higher” level of styrene exposure [26II] [26]
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Table 1 (Continued)
Study
(author, occupational
setting, country)
Study population Styrene Exposure
Mean SD
Duration
of exposure
Mean SD
(range)
CBMN assay1 QS Results and comments
(exposed vs controls)
Ref
Tomanin et al. (1992)
Fiberglass boats factory
(polyester resin), Italy [26II]
“Higher”level of styrene exposure
[26II]
Exposed (n =12)
gender: 5m+7f
smoking: 7sk + 5nsk
age: 3710
Controls (n =12)
gender: 4m+8f
smoking: 7sk + 5nsk
age: 377
Dose biomarkers:
Urinary MA (end shift)
725329mg/g creat.
Lymphocyte culture
CytB–3mg/mL
Slides stained with Giemsa
Visual scoring:
150–1450 BNCs/slide
L-MNed (m) $ (1.47) 11.18 vs
7.63
L-MNi (m) $ (1.49) 12.59 vs
8.47
L-CA (%total) " (3.68) 3.02 vs 0.82
“Lower”level of styrene exposure [26I]
L-MNed (m) $ (0.88) 8.07 vs
9.14
L-MNi (m) $ (0.86) 8.74 vs
10.21
L-CA (%total) $ (1) 1.43 vs 1.43
Small ﬁberglass tanks factory
(polyester resin), Italy [26I]
“Lower”level of styrene exposure
[26I]
Exposed (n =7)
gender: only males
smoking: 3sk + 4nsk
age: 296
Controls (n =7)
gender: 5m+2f
smoking: 3sk + 4nsk
age: 314
Dose biomarkers:
Urinary MA (end shift)
186114mg/g creat.
9.07.3 years 15 All population:
L-MNi (m) were correlated with urinary
levels of MA.
No correlations were found between
length of exposure and cytogenetic
endpoints studied.
Vodicka et al. (2004)
Reinforced-plastic lamination
plants
(Plant A), Czech Republic
Exposed (n =35)
gender: 20m+15f
smoking: 15sk + 20nsk
age: 3713
Controls (n =16)
gender: only males
smoking: 2sk + 14nsk
age: 498years
Air:
26.413.5 ppm*
Dose biomarkers:
Urinary MA+PGA (end shift)
798419mg/g creat
Styrene level in blood (mg/L)
Exposed: 0.710.47
Controls: 0.070.06
5.33.4 years Whole blood culture
CytB–6mg/mL
Slides stained with Giemsa
Visual scoring:
1000 BNCs/slide
13 L-MNed (m) " (1.54) 17.9 vs 11.6 [29]
L-CA (%) $ (1.47) 2.5 vs 1.7
SSB in DNA
(SSB/109Da)
# (0.28) 0.16 vs 0.57
L-MNed (m) of all exposed population was
associated with: air levels of styrene in air
and blood, urinary metabolites and
comulative exposure index (air*duration
of exposure). Data not shown by authors
Strong correlations were also found
between all exposure biomarkers (air,
blood and urine).
Abbreviations: m, male, f – female, sk – smokers, nsk – non-smokers; MA, mandelic acid; PGA- phenylglyoxylic acid, TWA- time-weighted average of exposure, 4-VPT- total 4-vinylphenols (minor styrene metabolites), creat-
creatinine; CytB, cytochalasin B, BNCs- binucleated cells; QS, quality study score; L – lymphocytes; MNed, micronucleated binucleated cells; MNi- binucleated cells with micronuclei,; CAs-chromosomal aberrations; SCE-sister
chromatid exchange assay; TL, SSB in DNA, %TDNA and TD are all parameters measured by comet assay: TL-tail length, SSB- single strand breaks; %TDNA-percentage tail DNA; TD- percentage tail DNA correctedmean value (negative
internal standard); N-MN nasal micronucleus assay; DAPI 4,6-diamidino-2-phenylindole.;$, no signiﬁcant effect; "- signiﬁcant increase, #- signiﬁcant decrease, following number in brackets indicates fold increase or decrease.
1 L-CBMN assay protocol: culture, stain used and number of binucleated cells (BNCs) scored.
# mEH enzymatic activity (expected), classiﬁcation of EPHX1 genotypes according to Sarmanova et al. [69].
* values converted from mg/m3 to ppm (1ppm airborne styrene = 4.26mg/m3 airborne styrene).
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S. Costa et al. / Mutation Research 770 (2016) 92–105 99[26–28,30] the levels found were below the limit value of 800 mg/g
recommended by ACGIH1 [38]. Styrene concentration in venous
blood was assessed by Vodicka et al. [29] and Hannova et al. [34], in
both studies the biological exposure indice (BEI) of 0.2 mg/L was
exceeded. Overall in six of the eleven studies (seven of the thirteen
exposed groups) workers presented levels of exposure to styrene
above international reference values.
3.2.1. CBMN assay
Micronucleus frequency was increased in twelve of the thirteen
styrene-exposed groups, but only ﬁve reached signiﬁcance
[28,29,31–33].
Tomanin et al. [26] found a non-signiﬁcant decrease on
micronucleus frequency in group I “lower” level of exposure
however, it should be noted the limited number of individuals
analysed (there was an outlier in the control group). When the two
groups of workers were considered together micronucleus
frequency was increased in workers compared to controls, but
not signiﬁcantly.
Most studies evaluated the effects of potential confounders
such as smoking, age, and gender on micronuclei frequencies. Two
studies [30,28] reported a signiﬁcant increase of micronucleus
frequency in smokers. Migliore et al. [32] found a signiﬁcant
decrease in centromere-negative micronuclei (MN-FISH assay)
among smokers, but total micronuclei were not affected by this
confounder. Anwar and Shamy [27] and Teixeira et al. [35] enrolled
only non-smokers. Age signiﬁcantly inﬂuenced micronuclei
frequency in six studies [29,30,32,34–36], but in three [26–28]
no signiﬁcant association was found; no data was reported in the
other studies [31,33]. Concerning gender, ﬁve studies reported a
signiﬁcant increase of micronucleus frequency in females com-
pared to males [29,31,34–36], although in Migliore et al. [32] the
difference disappeared when corrected for age. Tomanin et al. [26]
did not assess the inﬂuence of gender on the endpoints studied.
The four studies remaining only enrolled male subjects
[27,28,30,33].
Concerning dose/exposure-response relationships, ﬁve studies
reported a signiﬁcant positive association between micronuclei
frequency and styrene exposure measured in air [29], internal doseFig. 2. Summary diagram representing the fold change of micronucleated binucleated
styrene exposed workers compared to referents (CAs-chromosomal aberrations; SCE-sbiomarker [26,29,32] or duration/years of exposure [28–30]. For
the remaining studies no signiﬁcant association was found either
for micronuclei or other effect biomarker, with the exception of
Teixeira et al. [35] for sister-chromatid exchange frequency
(correlation with air and urine levels).
3.2.2. CBMN assay vs other biomarkers
Other genotoxicity biomarkers besides micronuclei were
analysed in peripheral blood lymphocytes of styrene exposed
workers, namely chromosomal aberrations (CAs), sister-chromatid
exchange (SCE) and comet assay (DNA damage assessed by
different parameters). Most studies have evaluated one
[26,27,30–34] or two [28,29,35,36] of the above endpoints,
however due to numerical and practical reasons (e.g. different
assays used among studies) no statistical evaluation of the
agreement between assays and CBMN was possible. A descriptive
comparison of results from the lymphocyte CBMN assay and other
DNA damage biomarkers is shown in Fig. 2. With the exception of
Hanova et al. [34] all studies reported signiﬁcant positive increases
in one of the genotoxicity biomarkers evaluated. CAs frequencies
were assessed in four studies [26,27,29,32] with two studies
reporting signiﬁcant increases in workers compared to referents
[26,27]. Anwar and Shamy [27] reported a positive association
between micronuclei and CA, whereas no association was found in
Vodicka et al. [29] study. All studies measuring SCE reported
signiﬁcantly higher frequencies in workers compared to controls
[28,31,35,36]. A total of seven studies reported data on DNA
damage evaluated by comet assay [28–30,34–36] with positive and
negative outcomes. None of the studies reported association
between micronuclei and SCE frequencies, nor with the comet
assay parameters. Besides peripheral blood lymphocytes other
tissues/cells were analysed to assess styrene genotoxicity, namely,
nasal epithelial cells tested for micronuclei formation [30] and
sperm cells assessed for DNA damage by the comet assay [33]. In
the ﬁrst study, micronucleated nasal cells were signiﬁcantly higher
in workers compared to referents. Moreover a positive correlation
with average styrene exposure was observed, but no association
between micronuclei formation in nasal cells and lymphocytes
was detected. Migliore et al. [33] found a positive correlation cell (MNed) frequencies and other genotoxicity biomarkers in lymphocytes (L) of
ister chromatid exchange assay; *P < 0.05, signiﬁcant difference reported).
100 S. Costa et al. / Mutation Research 770 (2016) 92–105between the frequency of micronuclei in peripheral lymphocytes
and DNA damage in sperm cells, even when adjusted for age.
3.3. Laboratory methods
All studies selected for the meta-analysis applied the CBMN
assay. Cell cultures were prepared from whole blood [28,
30–33,35,36] or from lymphocytes isolated from whole blood
samples [26,27,29,34]. Cytochalasin B (CytB) was added at a ﬁnal
concentration of 6 mg/mL after 44 h incubation in nine studies [28–
36]; Tomanin et al., [26] and Anwar and Shamy [27] added 3 mg/mL
CytB after 32 h of cells incubation. The stain used in most studies
was Giemsa, with the exception of Laffon et al. [28] that used 4,6-
diamidino-2-phenylindole (DAPI). Different references were given
regarding scoring criteria [39–46]. All but two studies [26,27]
scored a minimum of a thousand binucleated lymphocytes per
subject.
3.4. Meta-analysis
After applying inclusion criteria eleven studies, further broken
down in thirteen groups, evaluating the frequency of micro-
nucleated cells (MNed) in subjects exposed to styrene were
included in the meta-analysis. Six of them evaluated also micro-
nuclei frequency (MNi). A forest plot reporting for each study mean
ratio (MR) estimate and relative 95% conﬁdence intervals (95% CI)
is shown in Fig. 3. All studies but Tomanin et al. [26I] showed an
increased frequency of MNed in exposed subjects, ranging from a
MR of 1.06 (0.85; 1.31) to a maximum of 2.23 (1.58; 3.13), six of
them reaching statistical signiﬁcance. The high heterogeneity
between studies (I2 = 67%; P < 0.001) recommended the use of
random effects model to estimate a meta-MR of 1.34 (1.18; 1.52;
P < 0.001). The same analysis was applied to those studies
evaluating MNi, and parallel results were found with an overall
estimate of 1.29 (1.04; 1.60). To take into account the inﬂuence of
single studies on meta-estimates of effect, the funnel plot and the
Egger test, were evaluated together with sensitivity analysis. TheReferences
Anwar and Shamy [27] 
Costa et al.  [36] 
Godderis et al.  [30] 
Hanova et al.  [34II ] 
Hanova et al.  [34I] 
Laffon et al.  [28]
Migliore et al. [33]
Migliore et al. [32]
Teixeira et al. [31]
Teixeira et al. [35]
Tomanin et al. [26II ]
Tomanin et al. [26I]
Vodicka et al.  [29]
Overall  (I² = 66.9%, p < 0.001)
1.319 
Fig. 3. Forest plot of the effect of styrene exposure on micronuclei frequfunnel plot for the thirteen study groups on MNed can be observed
in Fig. 4. The triangular distribution of studies included in the
meta-analysis shows the expected inverse relationship between
the effect estimates from individual studies against the standard
error of the effect. The shape of the ﬁgure and the inclusion of most
studies within the triangle stand for a low probability of
publication bias. The lack of asymmetry in the funnel plot was
conﬁrmed by the Egger test (P = 0.253). Sensitivity analysis was
performed removing all studies one by one and rerunning the
analysis. The results of all estimates of the meta-MR ranged from
1.30 to 1.37. Results for the MNi were similar and were not reported
here. The meta-regression analysis which reported the adjusted
estimate of the styrene effect taking into account possible
confounding variables such as gender, age and smoking habits is
reported in Table 2. Interestingly the heterogeneity in this model
dropped to non-signiﬁcant values, conﬁrming the validity of the
analysis. Also this model estimated an effect of exposure in the
range of 30% conﬁrming the reliability of the meta-analysis (meta-
MR 1.39; 95% CI 1.28-1.51). No association was found with selected
dose biomarker (urinary MA + PGA) nor with duration of exposure
in six studies.
The inclusion of quality score (QS) into the meta-analysis did
not substantially modiﬁed the results presented above. In Fig. 5 the
study groups were stratiﬁed by tertiles of QS and a meta-MR was
estimated for each tertile. The results ranged from 1.43, to 1.30, to
1.34 without any evident trends by study quality. When also the
term for quality was included in the meta-regression model for the
MNed, the meta-MR for styrene exposure increased to 1.48,
although the term did not signiﬁcantly contributed to the model
(MR = 1.00, P = 0.842).
4. Discussion
Previous reviews were inconclusive with regard to micronu-
cleus assay sensitivity to evaluate genomic instability and/or DNA
damage in human lymphocytes induced by styrene occupational
exposure. Across the studies appraised different methodologies1.34 (1.18, 1.52)
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Fig. 4. Funnel plot with studies distribution within pseudo 95% conﬁdence limits.
Table 2
Random effect modelling of meta-regression estimates.
Variable Mean Ratio 95% Conﬁdence interval P-value
Pooled random effect
Controls 1.00
Exposed 1.38 1.28–1.50 <0.001
%D Males between Exposed and Controls 0.98 0.97–0.99 0.008
%D smokers between Exposed and Controls 1.02 1.01–1.03 0.009
D mean age between Exposed and Controls 1.07 1.04–1.11 0.001
References
QS 13-16
Laffon et al.  [28]
Tomanin  et al.  [26I]
Vodicka et al.  [29]
Subtotal  (I² = 75.8%, p = 0.016)
QS 17-18
Anwar and Shamy  [27]
Hanova et al. [34II] 
Hanova et al. [34 I] 
Migliore et al. [33]
Tomanin  et al. [26II ]
Subtotal  (I² = 74.7%, p = 0.003)
QS 20-22
Costa et al. [36]
Godderis et al. [30]
Migliore et al. [32]
Teixeira et al. [31]
Teixeira et al. [35]
Subtotal  (I² = 35.3%, p = 0.186)
Overall  (I² = 66.9%, p < 0.001) 1.34 (1.18, 1.52)
MR (95% CI)
2.23 (1.58, 3.13)
1.31 (0.99, 1.72)
1.48 (1.08, 2.03)
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1.50 (1.34, 1.68)
1.06 (0.85, 1.31)
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Fig. 5. Forest plot of the inﬂuence of quality scores (QS) on results obtained for overall effect of styrene in micronuclei frequencies, with mean ratio (MR) estimates.
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studies [47–50]. Our systematic review focused on studies using
CBMN assay selected eleven studies published between 1992 and
2012 eligible for meta-analysis. The analyses revealed convincing
evidence linking exposure to styrene with micronuclei frequency.
Consistency among studies was good indicating that subjects
exposed to styrene have about 30% higher level of DNA damage
measured by CBMN assay, regardless of gender, age or smoking
status. It should be noted that the inclusion of a study-quality score
(QS) into the meta-analysis did not substantially modiﬁed the
estimated effect, meaning that the quality of the studies have no
inﬂuence in the association found. Hence, these results seems to
support the biological relevance of micronuclei testing (as
measured by CBMN) to evaluate genomic instability and/or DNA
damage in lymphocytes of subjects occupationally exposed to
styrene.
The present review has some limitations, the ﬁrst being the low
number of studies available in the literature for inclusion in the
meta-analysis which hindered more ﬁrm conclusions (e.g for dose
biomarker association, inﬂuence of confounders). A second aspect
found is related to the unbalanced number of females and smokers
between exposed and control groups in few studies. This is an
important issue since females in general have higher frequencies of
micronucleus than man and therefore inclusion of females in
group controls [26I, 34I] can potentially create negative bias.
Styrene is one of the components of tobacco and tobacco smoke,
however studies are conﬂicting regarding its inﬂuence on
micronucleus frequency. Nevertheless this mix did not inﬂuence
meta-estimates but may have contributed to some of the observed
inter-study heterogeneity. Thirdly, the risk of partial overlapping of
exposed groups between published papers cannot be completely
overruled since there is more than one study published by the
same research group. However, the presence of different socio-
demographic characteristics between studies seems to rule out
this inconvenient. Across studies there was insufﬁcient data on the
occupational activity of participants used as controls and on other
lifestyle variables such as dietary habits and alcohol intake that
may inﬂuence micronucleus frequency, thus this data was not
analysed. Finally, despite some studies have reported dose-effect
correlations [28–30,32] no ﬁrm conclusions can be drawn on the
association between dose biomarkers and micronucleus frequen-
cy. On the other hand, the results of this review, which are based on
the most recent research in the ﬁeld, are supported by the use of
restrictive criteria to select studies, and a technical homogeneity
which add values to the positive results, largely conﬁrmed by
individual studies, as evident by forest plots and sensitivity
analysis. The independence of risk estimates from confounding
factors and study quality further increases the reliability of these
results.
One of the main reasons pointed for the inconsistency of results
among previous studies was concurrent exposure to other
genotoxic substances. Therefore this issue was carefully analysed
and studies reporting co-exposure to other known genotoxic
chemicals were excluded from our analysis. By coincidence all
studies eligible for the analysis took place in reinforced-plastic
industries, according to IARC studies comprising glass ﬁbre-
reinforced plastics workers are more informative because they are
exposed to high levels of styrene and have less potential for
exposure to other substances [2]. Three studies reporting co-
exposure to other compounds (acetone, toluene, lead and
chromium) were included in the analysis. Acetone and toluene
air levels were <1% of the styrene concentration [31,35]. As for
metals tested because of control group occupation, the levels were
under reference limit values [30].
The low number of studies and the different internal dose
biomarkers evaluated limit possible conclusions on dose-effectrelationships. Biological monitoring of styrene in humans is
classically performed in urine or blood; the total concentration
of MA and PGA in urine sampled at the end of the work shift is the
most used internal-dose biomarker. In the present review the time
period between the ﬁrst study and the last is 20 years. During that
time the biological compound of reference changed (MA to
MA + PGA) as well as the biologic exposure indices and sampling
times (end of shift, prior to next shift). From our Table 1 we can
observe that ten of the eleven studies used urine as the biological
matrix of choice, six of which measured MA + PGA (earlier studies
only assessed MA). Air level of styrene exposure, personal
protective devices, workers tasks, type of moulding process and
sampling time are factors that may inﬂuence MA + PGA levels [51].
For all studies assessing environmental and biological monitoring
strong correlations were found between styrene air-levels and
MA + PGA levels (other studies did not assessed workplace air). As
for sampling time, half of the six studies sampled urine at the end
of shift and the other half prior to next shift. Nowadays, the end of
the shift is considered to be the best time for sampling urine for
MA + PGA analysis for styrene exposure biomonitoring. This may
explain why in studies that sampled urine prior to next shift
[31,35,36] no correlation was found between MA + PGA levels and
micronucleus frequency. On the other hand, MA + PGA levels reﬂect
the exposure at the moment of sampling and so are dependent of
workplace conditions (e.g. seasonality on working load) as for
micronucleus frequency is an expression of chronic exposure, a
measure of cumulative chromosomal damage, thus in such a
diverse and short number of studies the lack of association is not
surprising. Although no consistent association was found across
studies between CBMN assay and dose biomarkers evaluated, it
should be noted that styrene-exposed workers showed an increase
of micronucleus frequency in all studies analysed. So CBMN was
efﬁcient in detecting damage in a variety of exposure levels
measured by the different dose biomarkers used in the studies.
Duration of exposure and micronucleus frequency were
signiﬁcantly associated in three studies [28–30], the high
dispersion observed in working years and the minimum duration
criteria may explain the lack of signiﬁcant association in some
studies.
Some minor differences were identiﬁed across studies in
technical features of the CBMN assay that may have contributed for
the results found in some studies, namely lymphocyte culture (vs
whole blood culture) [26,27,34], time of Cyt-B addition and
concentration (3 mg/mL) [26,27]. It was observed that erythrocytes
are able to oxidize styrene to SO (styrene-genotoxic intermediate)
while lymphocytes have the potential to inactivate SO through
metabolism by microsomal epoxide hydrolase [52], a balance that
may be disrupted in lymphocyte cultures with the inactivation of
SO leading to different outcomes comparing to whole blood
cultures. The optimal Cyt-B concentration for lymphocyte isolated
cultures is 4.5 mg/mL, at 3 mg/mL Cyt-B was shown to be less
effective in blocking cytokinesis [53,54]. Another different aspect
identiﬁed in [26] and [27] studies critical to CBMN assay is the time
of Cyt-B addition. Cyt-B may take up to 6 h before it starts to exert
its cytokinesis-blocking action so ideally it should be added 6 h
before the ﬁrst mitosis so that all the observed binucleated cells are
in fact once-divided cells [54]. For lymphocytes is usually 44 h after
culture, in [26] and [27] it was added after only 32 h. According to
Fenech et al. [54] micronuclei tend to get lost in subsequent
divisions and the micronuclei frequency in a second division cell is
likely to be less than that in a ﬁrst division cell after a genotoxic
insult.
It is generally agreed that styrene exerts toxicity through its
metabolic conversion to SO and subsequent induction of DNA
damage [55] the metabolic rate of styrene is regulated at the
oxidation step by CYP2E1 [56]. DNA adducts induced by styrene
S. Costa et al. / Mutation Research 770 (2016) 92–105 103and SO have been consistently identiﬁed in human cells,
experimental animals, and occupationally exposed individuals
[3,57–59]. In vitro studies with human lymphocytes have
demonstrated SO ability to form DNA adducts and to cause
single-strand breaks and cytogenetic alterations in a dose-related
manner [60,61]. In human biomonitoring studies exposure
markers of styrene were found to correlate with lymphocyte
cytogenetic alterations and DNA strand-breakage measured by
comet assay [15,28,62]. Furthermore the majority of studies show
signiﬁcant increases in CAs frequency and to a lesser extent of SCE
frequency in styrene-exposed workers compared to referents [2].
The available data on styrene/SO genotoxicity from in vitro and
human in vivo studies suggests a clastogenic mode of action as the
primary mechanism of CA and micronucleus formation. Moreover,
DNA single-strand breaks (SSBs) has been suggested as the
principal lesion that leads to SCE formation. The mechanism is
likely to involve an unrepaired single-strand break converted to a
double-strand break upon replication fork collapse, and homolo-
gous recombination repair to facilitate accurate repair of lesion
[63].
In our review genetic polymorphism of styrene-metabolizing
enzymes such as CYP2E1, microsomal epoxide hydrolase, gluta-
thione-S-transferase (GST) M1, and GSTT1 were found to modulate
the levels of urinary metabolite concentrations [31] and cyto-
genetic endpoints [32,36]. Also in vitro experiments demonstrate
that CYP1A1, CYP2E1, EPHX1 and GSTP1 polymorphisms were
associated with the levels of genetic lesion induced by styrene and
SO in human leukocytes [64,65]. This is in agreement with several
other studies suggesting that genetic susceptibility may be
important in styrene-mediated genotoxicity [66,67]. However,
these results must be cautiously interpreted since the size of the
study populations limits the power of further conclusions.
Susceptibility is also linked to the individual capacity to repair
DNA lesions induced by exposure to genotoxic agents, a deﬁcient
repair may lead to genetic instability. Three studies included in the
present review have evaluated repair-genetic polymorphisms [30],
gene expression levels [34] and DNA repair capacity (g-ray and 8-
oxoguanine induced lesions) [29,34]. Micronucleus frequency was
signiﬁcantly affected by BER polymorphic gene XRCC1 (399) [30].
Interestingly mRNA expression levels of XRCC1, hOGG1 and XPC
were negatively correlated with styrene exposure biomarkers but
positively with SSBs measured by comet assay [34], which is in
accordance to [30] result and with the proposed styrene
genotoxicity mechanism. These results also suggests that BER
pathway plays an important role in the repair of styrene-exposure
induced DNA lesions. DNA repair capacity, determined by
challenge assay measured by comet assay was associated with
the duration of exposure to styrene [34] and styrene exposure
parameters [29]. Furthermore a study testing the effects of styrene
airborne-exposure on DNA damage and DNA repair at levels below
reference limit value (20 ppm) found an increased oxidative DNA
damage and induction of expression of DNA repair genes, as well as
a decreased DNA repair capacity [68]. These results highlight the
need for further research with a multiple biomarker approach
comprising larger populations and with reliable exposure charac-
terization (including concomitant exposures).
Overall an increase of micronucleus frequency in styrene-
exposed groups was observed, but only reached signiﬁcance in ﬁve.
Analysing the six studies where a non-signiﬁcant increase was
found [26,27,31,34–36] a number of factors mainly related to
biological sampling and CBMN methodology may have contributed
to the results observed.
In summary, our systematic review and meta-analysis of most
recent literature on styrene exposure identiﬁed a 34% overall
increase of genomic instability and DNA damage in exposed
workers as compared to unexposed controls (as measured byCBMN assay). The consistency of results in individual studies, the
independence of this result from major confounding factors and
form the quality of the study strengthens the evidence of risk
estimates.
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